BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8819694)

  • 1. Outpatient management of systemic lupus erythematosus.
    Sims GN; Smith HR
    Cleve Clin J Med; 1996; 63(2):94-100. PubMed ID: 8819694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy for systemic lupus erythematosus.
    Taylor JK; McMurray RV
    J Miss State Med Assoc; 2011 Feb; 52(2):39-43. PubMed ID: 21387869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.
    Arnaud L; Mathian A; Boddaert J; Amoura Z
    Drugs Aging; 2012 Mar; 29(3):181-189. PubMed ID: 22263748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus. How to manage, when to refer.
    Dall'Era M; Davis JC
    Postgrad Med; 2003 Nov; 114(5):31-7, 40. PubMed ID: 14650091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus.
    Klein-Gitelman MS; Miller ML
    Indian J Pediatr; 1996; 63(4):485-500. PubMed ID: 10832469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for juvenile-onset systemic lupus erythematosus.
    Carreño L; López-Longo FJ; González CM; Monteagudo I
    Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study.
    Bello N; Birt JA; Workman J; Zhou X; Ross-Terres JA; Petri M
    Adv Ther; 2022 Jul; 39(7):3131-3145. PubMed ID: 35534786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic lupus erythematosus].
    Aringer M; Hiepe F
    Z Rheumatol; 2011 Jun; 70(4):313-23. PubMed ID: 21688092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythmatosus - When to consider and management options.
    Apostolopoulos D; Hoi AY
    Aust Fam Physician; 2013 Oct; 42(10):696-700. PubMed ID: 24130970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
    Fujieda Y
    Immunol Med; 2020 Dec; 43(4):135-141. PubMed ID: 32459601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic approaches to therapy for systemic lupus erythematosus.
    Xiong W; Lahita RG
    Nat Rev Rheumatol; 2014 Feb; 10(2):97-107. PubMed ID: 24166241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
    Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
    Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic lupus erythematosus in children and adolescents].
    Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
    Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus: immunity gone awry.
    Tsokos GC
    Health News; 2002 Aug; 8(8):1-2. PubMed ID: 12206141
    [No Abstract]   [Full Text] [Related]  

  • 20. ANA-negative SLE presenting with nephritis and oculomotor palsy--a case report.
    Sircar S; Taneja VA; Kansra U
    Indian J Pathol Microbiol; 1997 Oct; 40(4):539-42. PubMed ID: 9444868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.